Response to "Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions" by Heidel et al

Affiliations

¹ Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy. barosig@smatteo.pv.it.
² Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi - Ospedale di Circolo, Varese, Italy.
³ Department of Hematology, Transfusion Medicine and Biotechnologies, Ospedale Civile, Pescara, Italy.
⁴ Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, Napoli, Italy.
⁵ Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, and Laboratorio Congiunto, University of Florence, Florence, Italy.
⁶ Italian Society of Tranfusion Medicine and Immunohematology (SIMTI), Roma, Italy.
⁷ Department of Medicine, Haematology Research Centre, Division of Experimental Medicine, Imperial College London, London, UK.
⁸ University of Bologna, Bologna, Italy.
⁹ Clinical Research Foundation (FROM), Ospedale Papa Giovanni XXIII, Bergamo, Italy.

Comment

Giovanni Barosi et al. Leukemia. 2018 Dec.

. 2018 Dec;32(12):2727-2728.

doi: 10.1038/s41375-018-0259-x. Epub 2018 Sep 28.

¹ Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy. barosig@smatteo.pv.it.
² Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi - Ospedale di Circolo, Varese, Italy.
³ Department of Hematology, Transfusion Medicine and Biotechnologies, Ospedale Civile, Pescara, Italy.
⁴ Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, Napoli, Italy.
⁵ Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, and Laboratorio Congiunto, University of Florence, Florence, Italy.
⁶ Italian Society of Tranfusion Medicine and Immunohematology (SIMTI), Roma, Italy.
⁷ Department of Medicine, Haematology Research Centre, Division of Experimental Medicine, Imperial College London, London, UK.
⁸ University of Bologna, Bologna, Italy.
⁹ Clinical Research Foundation (FROM), Ospedale Papa Giovanni XXIII, Bergamo, Italy.

No abstract available

Comment on

Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera.
Barbui T, Passamonti F, Accorsi P, Pane F, Vannucchi AM, Velati C, Gale RP, Tura S, Barosi G. Barbui T, et al. Leukemia. 2018 Sep;32(9):2077-2081. doi: 10.1038/s41375-018-0199-5. Epub 2018 Jun 28. Leukemia. 2018. PMID: 29955128 No abstract available.
Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions.
Heidel FH, Al-Ali HK, Hirt C, Kämpfe D, Jentsch-Ullrich K, Junghanss C, Nowak R, Schwarzer A, Spohn C, Vucinic V, Hochhaus A, Lange T; Working Party Myeloproliferative Neoplasms of the East German Study Group Hematology/Oncology (OSHO). Heidel FH, et al. Leukemia. 2018 Sep;32(9):2085-2087. doi: 10.1038/s41375-018-0214-x. Epub 2018 Jul 24. Leukemia. 2018. PMID: 30042412 No abstract available.